In 2016, the National Institute for Health and Care Excellence (NICE) released guidelines recommending people with asymptomatic advanced follicular low grade...
Treatment regimens involving the monoclonal anti-CD20 antibody rituximab are the standard of care for patients with CD20-positive non-Hodgkin lymphoma (NHL). It has...
